SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-024060
Filing Date
2019-04-26
Accepted
2019-04-26 15:47:24
Documents
5
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-2653_3defa14a.htm DEFA14A 32215
2 GRAPHIC g26533bgi001.gif GRAPHIC 55081
3 GRAPHIC g26533bgi002.gif GRAPHIC 88181
4 GRAPHIC g26533bgi003.gif GRAPHIC 24560
5 GRAPHIC g26533bgi004.gif GRAPHIC 3632
  Complete submission text file 0001104659-19-024060.txt   269812
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37926 | Film No.: 19771566
SIC: 2834 Pharmaceutical Preparations